Fernando Pio De La Hoz Restrepo
Universidad Nacional de Colombia
H-index: 48
Latin America-Colombia
Top articles of Fernando Pio De La Hoz Restrepo
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
How Possible Is the Elimination of Viral Hepatitis? An Analysis Based on the Global Burden of Disease from Hepatitis B and C, 1990–2019 | Microorganisms | Nelson Alvis-Guzman Nelson J Alvis-Zakzuk Fernando De la Hoz Restrepo | 2024/2/15 |
Heterologous and BNT162b2 boosters are more effective than non-mRNA homologous boosters for Omicron | Journal of Infection | Angel Paternina-Caicedo David Santiago Quevedo Diana Sofía Ríos Diane Moyano Nelson Alvis-Guzmán | 2024/4/24 |
La soledad como predictor de mortalidad en pacientes con cáncer. Un estudio de cohorte | Biomédica | Adriana Valdelamar Fernando De La Hoz Ricardo Sánchez | 2024/4/15 |
Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 | The Lancet Neurology | Jaimie D Steinmetz Katrin Maria Seeher Nicoline Schiess Emma Nichols Bochen Cao | 2024/4/1 |
Risk and protective factors for suicidal ideation and attempt in Latin American adolescents and youth: systematic review. | Violence against women | Ebony S Vinson Carrie B Oser | 2016/12 |
Factores asociados a la infección por el virus de la hepatitis B en comunidades indígenas de Colombia | Biomédica | Jaime Martinez-Gallego Diana Castro-Arroyave Juan Carlos Quintero Fernando de la Hoz Melissa Montoya | 2024/2/20 |
The high price that Colombia has paid for its lack of biotechnological sovereignty | The Lancet Regional Health–Americas | Camilo Guzman Salim Máttar Nelson Alvis-Guzmán Fernando De la Hoz | 2023/8/1 |
Comparative effectiveness and duration of protection of ChAdOx1, CoronaVac, BNT162b2, mRNA-1273, and Ad26. COV2. S COVID-19 vaccines for symptomatic and hospitalized Mu, Delta … | Vaccine | Angel Paternina-Caicedo David Santiago Quevedo Diana Sofía Ríos Diane Moyano Nelson Alvis-Guzmán | 2023/10/6 |
Educación en salud pública en Colombia: incidencia en las políticas públicas | Salud Pública de México | Fernando De la Hoz-Restrepo | 2023/1/27 |
EPH109 Excess Mortality from Diabetes Mellitus in the First Year of the Pandemic in Colombia | Value in Health | N Alvis-Guzman NJ Alvis Zakzuk F De La Hoz | 2023/6/1 |
Reductions in Childhood Pneumonia Mortality After Vaccination in the United States | The Pediatric Infectious Disease Journal | Angel Paternina-Caicedo Adrian D Smith Jeanine Buchanich Christian Garcia-Calavaro Nelson Alvis-Guzman | 2023/8/1 |
The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis | The Lancet Regional Health–Americas | Gisela Robles Aguilar Lucien R Swetschinski Nicole Davis Weaver Kevin S Ikuta Tomislav Mestrovic | 2023/9/1 |
Enhancement of HBV PMTCT is required because the status quo fails to protect those at highest risk | Philippa C Matthews Ponsiano Ocama Su Wang Manal El-Sayed Anna Turkova | 2023/11/1 | |
Public health education in Colombia: influence on public policies | salud pública de méxico | Fernando De la Hoz-Restrepo | 2023/1/27 |
EPH13 Trends in Mortality Related to Hepatitis C in Colombia 1997–2020 | Value in Health | N Alvis-Guzman J Alvis Zakzuk F Salcedo Mejía A Paternina-Caicedo MC Navas | 2023/6/1 |
HPR47 Access to Prenatal Care and Poverty in Colombian Regions: Before and in the Pandemic | Value in Health | N Alvis-Guzman F De La Hoz | 2023/6/1 |
Enhancing interventions for prevention of mother-to-child-transmission of hepatitis B virus | Philippa C Matthews Ponsiano Ocama Su Wang Manal El-Sayed Anna Turkova | 2023/8/1 | |
Reply to:“Does currently recommended maternal antiviral prophylaxis against mother-to-child transmission of hepatitis B virus require enhancement?” | JHEP Reports | Philippa C Matthews Ponsiano Ocama Su Wang Manal El-Sayed Anna Turkova | 2023/11/1 |
EE243 Cost-Effectiveness of Velpatasvir/Sofosbuvir for the Treatment of Hepatitis C in Colombia | Value in Health | A Paternina-Caicedo N Alvis-Guzman J Alvis Zakzuk F De La Hoz | 2023/6/1 |
HTA70 Use of Economic Evaluation of Vaccines: The Experience in Colombia, 2000 to 2021 | Value in Health | N Alvis-Guzman F De La Hoz | 2023/6/1 |
